CompanyGraphAt a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $1.29B, above the global median of $1.18B
- FinancialsAltman Z-Score 11.8: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
123.77BINR1.29B · vs all stocks (USD)
Trailing P/E
43.53xvs Medical Care Facilities peers
Revenue (TTM)
17.56BINR183.45M · vs all stocks (USD)
Profit Margin
16.09%vs Medical Care Facilities peers
52-Week Change
93.68%vs all stocks
Market Capitalization
123.77BINR1.29B · vs all stocks (USD)
Enterprise Value
113.67BINR1.19B · vs all stocks (USD)
Trailing P/E
43.53xvs Medical Care Facilities peers
Forward P/E
26.86xvs Medical Care Facilities peers
PEG Ratio
0.4465xvs Medical Care Facilities peers
Price to Sales (TTM)
7.00xvs Medical Care Facilities peers
Price to Book (MRQ)
5.61xvs Medical Care Facilities peers
Enterprise to Revenue
6.47xvs Medical Care Facilities peers
Enterprise to EBITDA
24.49xvs Medical Care Facilities peers
Gross Margin
64.54%vs Medical Care Facilities peers
Profit Margin
16.09%vs Medical Care Facilities peers
Operating Margin
22.55%vs Medical Care Facilities peers
Return on Assets (TTM)
9.18%vs Medical Care Facilities peers
Return on Equity (TTM)
12.27%vs Medical Care Facilities peers
Revenue (TTM)
17.56BINR183.45M · vs all stocks (USD)
Revenue per Share (TTM)
44.91INRUpdated Sep 23, 2026Quarterly Revenue Growth
19.30%vs Medical Care Facilities peers
Gross Profit (TTM)
11.15BINR116.49M · vs all stocks (USD)
EBITDA (TTM)
4.99BINR52.11M · vs all stocks (USD)
Net Income (TTM)
2.83BINR29.52M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
42.30%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
3.29BINR34.38M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.58BINR26.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00INRUpdated Sep 23, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
823.12MINRFY2026 · Mar 31, 2026Revenue
16.79BINRFY2026 · Mar 31, 2026Cost of Goods Sold
6.19BINRFY2026 · Mar 31, 2026Gross Profit
10.60BINRFY2026 · Mar 31, 2026Operating Income
3.82BINR39.89M · vs all stocks (USD)
Pre-tax Income
3.55BINRFY2026 · Mar 31, 2026Income Tax Expense
810.27MINRFY2026 · Mar 31, 2026Net Income
2.74BINRFY2026 · Mar 31, 2026EBIT
4.13BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
4.76BINRFY2026 · Mar 31, 2026Selling, General & Administrative
2.57BINRFY2026 · Mar 31, 2026Other Operating Expenses
3.59BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
588.85MINRFY2026 · Mar 31, 2026EPS (Basic)
6.87INRFY2026 · Mar 31, 2026EPS (Diluted)
6.87INRFY2026 · Mar 31, 2026Basic Shares Outstanding
375.72MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
375.72MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
-154.37MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
4.23BINRFY2026 · Mar 31, 2026Free Cash Flow
3.03BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
2.37BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
3.55BINRFY2026 · Mar 31, 2026Other Non-cash Items
291.08MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
556.42MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-165.16MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.20BINRFY2026 · Mar 31, 2026Net Acquisitions
-2.38BINRFY2026 · Mar 31, 2026Other Investing Activity
90.00KINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-3.57BINRFY2026 · Mar 31, 2026Net Financing Cash Flow
7.70BINRFY2026 · Mar 31, 2026Shares Outstanding
431.93MSharesUpdated Sep 23, 2026Float Shares
67.09MSharesUpdated Sep 23, 2026% Held by Insiders
83.94%vs all stocks
% Held by Institutions
5.75%vs all stocks
Total Cash (MRQ)
4.31BINR45.06M · vs all stocks (USD)
Total Cash per Share (MRQ)
10.72INRUpdated Sep 23, 2026Total Debt (MRQ)
3.64BINR38.04M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1731xvs Medical Care Facilities peers
Current Ratio (MRQ)
2.06xvs Medical Care Facilities peers
Book Value per Share (MRQ)
50.79INRUpdated Sep 23, 2026Total Assets
28.13BINR293.86M · vs all stocks (USD)
Total Current Assets
10.88BINRFY2026 · Mar 31, 2026Total Liabilities
7.09BINRFY2026 · Mar 31, 2026Total Non-current Assets
17.25BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
1.80BINRFY2026 · Mar 31, 2026Total Current Liabilities
5.29BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
2.37BINRFY2026 · Mar 31, 2026Other Short-term Investments
2.25BINRFY2026 · Mar 31, 2026Accounts Receivable
5.93BINRFY2026 · Mar 31, 2026Inventory
28.98MINRFY2026 · Mar 31, 2026Accounts Payable
1.09BINRFY2026 · Mar 31, 2026Short-term Debt
2.14BINRFY2026 · Mar 31, 2026Other Current Liabilities
180.42MINRFY2026 · Mar 31, 2026Long-term Debt
1.50BINRFY2026 · Mar 31, 2026Common Stock (Book)
863.86MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
21.04BINR219.81M · vs all stocks (USD)
52-Week Low
138.10INRUpdated Sep 23, 202652-Week High
305.00INRUpdated Sep 23, 202652-Week Change
93.68%vs all stocks
50-Day MA
282.47INRUpdated Sep 23, 2026200-Day MA
229.23INRUpdated Sep 23, 2026Avg 10-Day Volume
386.12KSharesUpdated Sep 23, 2026Avg 30-Day Volume
531.05KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
6.54INRUpdated Sep 23, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 11.8: safe zoneNotable
Altman Z-Score: 11.80
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.29B, above the global median of $1.18BNotable
Market cap (USD): 1,292,899,174.591Global Median: 1,180,223,658.953
Levered free cash flow is $26.96M, above the global median of $18.73MNotable
Levered free cash flow (USD): 26,963,215.2Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Atlanta Electricals Limited
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Mayaair Technology China Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Cotran New Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Shenzhen Q&D Circuits Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huapont Life Sciences Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Camel Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Suzhou Hycan Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Sunrise Electrical Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Unison Aluminium Products Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rpc Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Catalyst Pharmaceuticals Inc.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedCash-Flow Ratios Elevated
ASML Holding N.V.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedCash-Flow Ratios Elevated
Magnolia Oil & Gas Corp.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedCash-Flow Ratios Elevated